Replies to post #13646 on Endonovo Therapeutics Inc (ENDV)

[fly_fisherman]

Why I ask....

I disagree that there's no credibility with new clinicals. Sometimes you have to connect the dots on your own.

why must we have to connect the dots. I respect your opinion immensely Seaheck but this is not a game of guess what ENDV is hiding in their hands behind their back. We have to figure this out on our own asking questions and researching sites. I think its very important for company's wanting investing dollar (retail included here we do matter I think) to be transparent.

I am not asking for everything under the sun. I am simply asking for feedback regarding the items ENDV put on the table for the whole world to see and hear. Then pulled them back. One without any update whatsoever. That's craziness.

Clinical Q1/Q2 and the supposed health care investor and 15 million dollars to avoid dilution and payment of toxic debt.

We continue with toxic notes. Ridiculous especially while the president continues to buy shares. One begins to question what that is all about.

Its plain and simple to me.

I love the technology don't get me wrong but I do not love the company!! They will end up losing the patents and technology at this rate and along with it all of our investment dollars!!!

From what I see we cant afford the new clinical's. Remember they are doing this with diluted shares and more than likely more toxic funding.

That's another bone of contention. Why the darn toxic notes. If your diluting use those funds versus the toxic route with the incredibly huge interest rates and conversion rates. Why toxic. Just dilute some shares. Nuts...

I am open to your comments. Make me feel more comfortable.